Ge Long Hui·2026-02-10 10:31Core Viewpoint - Fosun Pharma's subsidiary Shanghai Chaohui Pharmaceutical has had its drug registration application for Benzocaine Gel accepted by the National Medical Products Administration, marking a significant step in the company's product development [1][2]. Group 1: Company Developments - The drug, Benzocaine Gel, is a chemical product independently developed by the group [1]. - It is intended for transdermal local anesthesia, specifically for skin anesthesia prior to venipuncture or intravenous catheterization [1]. - The product is suitable for adults and infants over one month old [1]. Group 2: Regulatory Milestones - The acceptance of the drug registration application by the National Medical Products Administration is a crucial regulatory milestone for the company [2].